- Home
- TS vs PODD Comparison
TS vs PODD Comparison
Compare TS & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TS
- PODD
- Stock Information
- Founded
- TS 2001
- PODD 2000
- Country
- TS Luxembourg
- PODD United States
- Employees
- TS N/A
- PODD N/A
- Industry
- TS Steel/Iron Ore
- PODD Medical/Dental Instruments
- Sector
- TS Industrials
- PODD Health Care
- Exchange
- TS Nasdaq
- PODD Nasdaq
- Market Cap
- TS 19.8B
- PODD 21.5B
- IPO Year
- TS N/A
- PODD 2007
- Fundamental
- Price
- TS $38.64
- PODD $290.28
- Analyst Decision
- TS Buy
- PODD Strong Buy
- Analyst Count
- TS 6
- PODD 19
- Target Price
- TS $43.33
- PODD $320.11
- AVG Volume (30 Days)
- TS 1.5M
- PODD 767.5K
- Earning Date
- TS 07-30-2025
- PODD 08-07-2025
- Dividend Yield
- TS 4.31%
- PODD N/A
- EPS Growth
- TS N/A
- PODD 67.46
- EPS
- TS 1.63
- PODD 5.55
- Revenue
- TS $12,004,602,000.00
- PODD $2,198,900,000.00
- Revenue This Year
- TS N/A
- PODD $24.49
- Revenue Next Year
- TS $0.04
- PODD $17.45
- P/E Ratio
- TS $11.19
- PODD $52.13
- Revenue Growth
- TS N/A
- PODD 23.48
- 52 Week Low
- TS $27.24
- PODD $173.00
- 52 Week High
- TS $40.87
- PODD $329.33
- Technical
- Relative Strength Index (RSI)
- TS 64.05
- PODD 36.89
- Support Level
- TS $37.85
- PODD $293.38
- Resistance Level
- TS $38.97
- PODD $300.00
- Average True Range (ATR)
- TS 0.65
- PODD 7.24
- MACD
- TS 0.10
- PODD -1.88
- Stochastic Oscillator
- TS 90.86
- PODD 6.98
About TS Tenaris S.A.
Tenaris is one of the largest global producers of oil country tubular goods, which are used primarily in the construction of oil and gas wells. Its production facilities are located primarily in the US, Argentina, Mexico, and Italy. Tenaris' premium OCTG products are among the most trusted by oil companies for use in the most challenging applications, including deep-water offshore wells and horizontal shale wells.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.